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Abstract
In this communication, we demonstrate that galectin (Gal)-9 acts to constrain CD8
+ T cell immunity to Herpes Simplex Virus
(HSV) infection. In support of this, we show that animals unable to produce Gal-9, because of gene knockout, develop acute
and memory responses to HSV that are of greater magnitude and better quality than those that occur in normal infected
animals. Interestingly, infusion of normal infected mice with a-lactose, the sugar that binds to the carbohydrate-binding
domain of Gal-9 limiting its engagement of T cell immunoglobulin and mucin (TIM-3) receptors, also caused a more
elevated and higher quality CD8
+ T cell response to HSV particularly in the acute phase. Such sugar treated infected mice
also had expanded populations of effector as well as memory CD8
+ T cells. The increased effector T cell responses led to
significantly more efficient virus control. The mechanisms responsible for the outcome of the Gal-9/TIM-3 interaction in
normal infected mice involved direct inhibitory effects on TIM-3
+ CD8
+ T effector cells as well as the promotion of Foxp3
+
regulatory T cell activity. Our results indicate that manipulating galectin signals, as can be achieved using appropriate
sugars, may represent a convenient and inexpensive approach to enhance acute and memory responses to a virus infection.
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Introduction
Adaptive immune responses to foreign antigens require precise
regulation. If not, excessive bystander damage to host tissues may
occur and an unlimited reaction could erode the size of the
repertoire, limiting responses to other antigens. It is evident that
the host possesses several mechanisms that control the size,
composition and duration of immune reactions [1]. In conse-
quence, after the primary response most cells die leaving a
memory population that represents a fraction of the cells that
responded initially to the antigen. Moreover, these memory cells
rarely account for .10% of the total antigen reactive repertoire
[2]. In some circumstances, it would be desirable to expand the
size of the memory population and perhaps extend the durability
of effector cell activity, since this could improve immunity to
certain pathogens. HIV is such an example [3]. Accordingly,
understanding how immune responses are constrained could
provide clues to reverse the process and improve the efficacy of
vaccines.
One family of host proteins that plays multiple roles in innate
and adaptive immunity is the galectin proteins. These glycan
binding proteins either form lattices on cell surfaces or react with
specific receptors and trigger a variety of responses that include
apoptosis and changes of cell function [4]. Some galectins bind to
the surface of pathogens and this may influence pathogen
infectivity and survival [5]. For instance, binding of Gal-1 to
HIV increases infectivity of the virus for macrophages [5,6]. At
least two family members, Gal-1 and Gal-9, may play an effective
role in terminating the acute inflammatory response as well as
restricting the extent of chronic lesions in autoimmune and allergic
reactions [4,7]. Recently, we showed that chronic inflammatory
reactions caused by HSV infection of the eye was limited by Gal-9
binding to its specific receptor TIM-3 [8]. This interaction led to
inhibitory effects on effector T cells, as well as the expansion of
regulatory T (Treg) cell activity.
Currently, it is not clear what role galectins play at regulating
acute immune responses to virus infections and whether
manipulating galectin binding to their receptors can influence
the magnitude and effectiveness of anti-viral immunity. In this
communication, we investigate the influence of Gal-9 binding to
its receptor TIM-3 on the size and quality of CD8
+ T cell
mediated immunity to a virus infection. We demonstrate that Gal-
9 acts to limit the extent of CD8
+ T cell immunity to HSV
infection. In support of this, we show that animals unable to
produce Gal-9, because of gene knockout, develop acute and
memory responses to HSV that are of greater magnitude and
better quality than those that occur in normal infected animals.
We also make what we believe is the novel observation that
infusion of normal infected mice with a-lactose, the sugar that
binds to the carbohydrate-binding domain of Gal-9 limiting its
TIM-3 receptor engagement [9], also caused a more elevated and
higher quality CD8
+ T cell response to HSV. Such sugar treated
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+ T
cells. The mechanisms responsible for the outcome of the Gal-9/
TIM-3 interaction in normal infected mice involved both
inhibitory effects on TIM-3
+ T effector cells, as well as the
promotion of Foxp3
+ regulatory T cell activity. Our results
indicate that manipulating galectin signals, as can be achieved
using appropriate sugars, may represent a convenient and
inexpensive approach to enhance acute and memory responses
to infectious agents and might be useful to improve responses to
some vaccines.
Materials and Methods
Ethics statement
All animals were housed in Association for Assessment and
Accreditation of Laboratory Animal Care (AAALAC)-approved
animal facilities. Institutional Animal Care and Use Committee
(IACUC), The University of Tennessee, Knoxville approved all
experimental protocols and experiments were performed adhering
to protocols created by the committee.
Mice and virus
Female 5–6-wk-old C57BL/6 and congenic Thy1.1
+ B6.PL (H-
2
b) mice were purchased from Harlan Sprague-Dawley and
Jackson Laboratory, respectively and housed in the animal
facilities at the University of Tennessee, Knoxville. Galectin-9
KO (Gal-9 KO) mice were kindly provided by GalPharma Co.
Ltd, Japan. Dr. Thandi Onami kindly provided P14 LCMV
transgenic mice. Foxp3-GFP knock-in mice were kindly provided
by Dr. Mohammed Oukka of Harvard Medical School. HSV-1
strain KOS was grown in Vero cells obtained from American
Type Culture Collection. The harvested virus was titrated and
stored in aliquots at 280uC until further use.
Antibodies and reagents
Conjugated antibodies purchased from BD Bioscience were
anti-CD8a, anti-CD25c anti-CD62 ligand (CD62L), anti-CD44,
anti-CD69, anti-IFN-c, anti-TNF-a, anti-IL-2, anti-CD25 (7D4),
anti-KLRG1, anti-CD80, anti-CD86, anti-CD11b, anti-CD11c,
anti-CD40, anti-MHC class II and anti-CD103. PE and APC
conjugated TIM-3 antibodies were purchased from R&D Systems.
Intra-nuclear Foxp3 staining was performed using a kit from
ebioscience according to the instructions. Carboxyfluorescein
Succinimidyl ester (CFSE) was obtained from Molecular Probes.
HSV gB498–505 peptide (SSIEFARL) was supplied by Genescript.
PE- and APC-Kb-gB tetramer was kindly provided by NIH
tetramer core facility, Emory University, Atlanta, GA. Recombi-
nant galectin-9 and anti-galectin-9 antibodies (clone1A2 and
108A2) were provided by Gal Pharma, Japan. Recombinant
galectin-3 was obtained from R & D systems. a-Lactose was
purchased from Acros organics (Geel, Belgium). The antibody-
stained cells were acquired with a FACS Calibur (BD Biosciences)
and the data were analyzed using the FlowJo software (Tree Star,
OR). Sorting of cells was performed by using a FACS Vantage
system.
Infection of mice, treatment with galectin-9 and
a-lactose
Mice were infected in footpad (FP) with 2.5610
5 PFU of HSV
KOS in 30 ml volume. For memory recall response studies,
animals were challenged with the same amount of virus in the
footpads after a period of at least 30 days. For primary responses,
infected animals were divided randomly into different groups.
Mice in one group were treated ip with 125 mg of Gal-9 twice daily
starting from day 3 until day 5 post infection (p.i). Similarly
animals in other groups were treated twice daily starting from day
3 until day 5 with various doses (27 mM, 137 mM, 277 mM and
416 mM) of a-lactose solution made in PBS. For some memory
experiments, animals were provided with 277 mM of a-lactose
solution in drinking water for 10 days. 12 hrs after the last
treatment animals were sacrificed and their isolated lymphoid
organs were made into single cell suspension for flow cytometric
analysis.
Quantification of HSV-1 in foot pad tissues
The quantification of HSV-1 in footpad tissue was done as
previously reported [10]. Briefly, the mice were sacrificed at the
indicated time p.i., the footpad surface was cleaned with 70%
isopropyl alcohol, cut and were stored in RPMI without serum
and 2-mercaptoethanol at -80uC until use. Tissues were disrupted
by chopping with scissors and homogenized by using a
homogenizer (Pellet Pestle mortar; Kontes) and centrifuged. The
supernatant was used to assess viral titers on Vero cells. Finally,
plaques were visualized after staining with crystal violet.
Adoptive transfer of cells
Different numbers of cells obtained from pooled spleen and
Lymph nodes (LN) of Thy1.1 LCMV (P14) transgenic animals
were transferred into Thy1.2 C57BL/6 animals that were then
infected with HSV-KOS in footpads. At 5dpi, LCMVgp33-Tet
+
and Kb-gB-Tet
+ cells were analyzed for the expression of TIM-3.
The control animals not transferred with any cell type were
similarly infected with HSV KOS. Similarly, for some other
experiments, cells obtained from pooled LNs and spleens of B6
Thy1.1 animals were labeled with 2.5 mM of CFSE. 10
7 of these
cells were transferred into B6 Thy1.2 wild type and galectin-9
knockout animals. Alternatively, CD8
+ T cells obtained from Gal-
9 KO and WT animals (both Thy1.2) were CFSE labeled and
transferred into Thy1.1 C57BL/6 animals. After 24 hrs of transfer,
recipient animals were infected with 2.5610
5 PFU of HSV 1
KOS. After five days of infection LNs and spleens were isolated
Author Summary
Adaptive immune responses to foreign antigens require
precise regulation, otherwise excessive bystander damage
to host tissues may occur and responses to other antigens
could be compromised. Some galectin proteins binding to
receptors on cells of the immune system form part of the
regulatory system, although this topic has received scant
attention as it relates to antiviral control. In this report, we
evaluate the role of the galectin-9/TIM-3 receptor pathway
at regulating acute and memory CD8
+ T cell responses to
herpes simplex virus (HSV) infection. We demonstrate that
CD8
+ T cell responses to HSV were significantly increased
in magnitude and improved in quality in mice unable to
produce galectin-9 because of gene knockout compared
to wild type controls. Furthermore, inhibiting the galectin-
9 mediated response to TIM-3 using the sugar alpha-
lactose that binds to Gal-9 led to a similar response
pattern. The influence of galectin-9 to constrain CD8
+ T cell
responses involved direct inhibitory effects on the T
effectors as well as the promotion of regulatory T cell
responses. Our results indicate that manipulating the
interaction of galectins with receptors using simple sugars
may represent a convenient and inexpensive approach to
enhance T cell responses to virus infections, and could
prove useful to increase the efficacy of some vaccines.
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was analyzed flow cytometrically in Thy1.1
+ or Thy1.2
+CD8
+ T
cells.
SSIEFARL-specific CD8
+ T cell proliferation
CD8
+ T cell proliferation was evaluated after in vitro
stimulation of splenocytes and draining LN cells obtained from
HSV infected mice with MHC class I (H-2K
b)–restricted
SSIEFARL peptide. Briefly, the cells were stimulated with
SSIEFARL peptide (1 mg/ml) for 3 days in the presence of
100 U/ml of IL-2. [
3H] Thymidine (1 mCi/well) was added to
each well 18 h before harvest. Harvested cells were measured for
radioactivity using a b-scintillation counter (Inotech).
In vivo CTL assay
The in vivo CTL assay was done as reported earlier [11].
Splenocytes from naive B6 mice were used as target cells and split
into two equal populations. One was pulsed with 2.5 mgg B 498–505
peptide for 45 min at 37uC and then labeled with a high
concentration (2.5 mm) of CFSE. The other population was un-
pulsed and labeled with a low concentration of CFSE (0.25 mm).
Equal numbers of cells from each population (10
7) were mixed
together and adoptively transferred i.v. into naı ¨ve and HSV-1–
infected mice. Splenocytes and peripheral blood were collected 2 h
after adoptive transfer from recipient mice, erythrocytes were
lysed, and cell suspensions were analyzed by FACS Calibur
system. Each population was distinguished by their respective
fluorescence intensity. Assuming that the number of peptide-
pulsed cells injected is equivalent to the number of no peptide-
pulsed cells injected, the percentage of killing of target cells in
uninfected animals was determined as:
Percentage of CFSElow{percentage of CFSEhigh 
|100
 
PercentageCFSElow:
The percentage killing of target cells in infected animals was
calculated as:
Ratio~ Percentage of CFSElow
percentage of CFSEhigh 
:
Percentage specific lysis~ 1{ ratio uninfected=ratio infected ðÞ ½
|100 :
Intracellular Cytokine Staining Assay (ICCS)
To enumerate the number of IFN-c, TNF-a and IL-2
producing T cells, intracellular cytokine staining was performed
as previously described [12]. In brief, 10
6 freshly isolated
splenocytes were cultured in U bottom 96-well plates. Cells were
left untreated or stimulated with SSIEFARL peptide (2 mg/ml),
and incubated for 5 h at 37uCin 5% CO2. Brefeldin A (10 mg/ml)
was added for the duration of the culture period to facilitate
intracellular cytokine accumulation. After this period, cell surface
staining was performed, followed by intracellular cytokine staining
using a Cytofix/Cytoperm kit (BD PharMingen) as per the
manufacturer’s recommendations. The Ab used were anti–IFN-c
(clone XMG1.2), anti-TNF-a (clone MP6-XT22), and anti-IL-2
(clone JES6-5H4). The fixed cells were re-suspended in FACS
buffer (PBS with 3% heat inactivated serum) and analyzed flow
cytometrically.
Ex vivo apoptosis assay
PLNs single cell suspension isolated 6 days pi from HSV
infected animals were incubated for 5 hrs with varying concen-
trations of Gal-9 or Gal-3 in the absence or the presence of a-
lactose in 96-well flat-bottom plates in humidified incubators in the
presence of 5% CO2. After the incubation period was over, cells
were stained for annexin V using a kit from BD Biosciences.
Additionally, cells were also co-stained for CD8, TIM-3, Kb-gB-
Tet. Stained cells were analyzed immediately by flow cytometry.
In vitro suppression assay
At 6 dpi, Foxp3
+CD4
+ T cells were FACS sorted on a FACS
Vantage system to the extent of 97.8% purity from HSV infected
Foxp3-GFP-Knock-In animals that were either untreated or
treated with 200 ml of 277 mM a-lactose i.p. from day 3 to day
5. Foxp3
+ T cells were then cultured with anti-CD3 stimulated
CFSE labeled CD4
+CD25
2 Thy1.1 (MACS purified) and T cell
depleted irradiated splenocytes for three days. Thereafter, the
extent of CFSE dilution in Thy1.1
+CD4
+ T cells was analyzed
flow cytometrically.
Immunoblotting and ELISA for the detection of galectin-
9 expression and quantification
Lymph node and spleen homogenate samples (10 mg/lane) were
resolved on 15% SDS-PAGE and transferred electrophoretically
on to a PVDF membrane (Bio-Rad). The membrane was blocked
overnight with 5% BSA and washed 5 times with TBS containing
0.05% Tween-20 (TBST) and incubated with biotinylated anti-
galectin antibody (R&D Systems) at a concentration of 0.5 mg/ml
diluted in TBST for 1 hr at room temperature. The membrane
was washed 5 times with TBST and incubated with streptavidin-
HRP antibody (Pierce) at a dilution of 1:10000 for 1 hr at room
temperature. The membrane was developed with chemilumines-
cent substrate (Immobilon western chemiluminescent HRP
substrate, Millipore) and the image was taken on CL-XPosure
X-ray film (Thermo scientific).
Ninety-six-well microplates were coated with capture antibody
at a concentration of 3000 ng/ml (100 ml/well, anti-galectin-9,
GalPharma Co. Ltd, Japan). After incubation overnight at 4uC,
the wells were washed three times with PBST (PBS containing
0.05% Tween-20) and blocked with 5% BSA for 2 h at RT. The
wells were washed three times with PBST and Lymph node, spleen
homogenate samples (100 ml) were added to the wells and
incubated at RT for 2 h and aspirated. The wells were then
washed with wash buffer. Biotinylated anti galectin detection
antibody (1;10000, R&D Systems) diluted in reagent diluent (R&D
Systems, PBS, 5% Tween 20, 2% goat serum) was added to each
well and incubated at RT for 1 h. The wells were then washed
three times and 100 ml of streptavidin–horseradish peroxidase
(1:10000 dilution) added and incubated for 1 hr at room
temperature. The plate was washed thrice and developed with
TMB (R&D systems) substrate and the absorbance of each sample
was determined at 450 nm. A standard curve ranging from 5 mgt o
156.25 ng of recombinant galectin-9 (Gal Pharma, Japan) was
generated to calculate the galectin-9 concentration in the unknown
samples.
Statistical analysis
Most of the analyses for determining the level of significance
were performed using Student’s t test by Graphpad software.
Gal-9/TIM-3 Pathway in Anti-Viral Immunity
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significant. Results are expressed as mean 6 SEM or otherwise
stated.
Results
Virus-specific CD8
+ T cells up regulate TIM-3 expression
after HSV infection
CD8
+ T cells isolated from the draining popliteal LNs (PLN)
and spleens of HSV infected animals were analyzed for TIM-3
expression at different times pi. As is evident in Fig 1A, whereas
few CD8
+ T cells isolated from LNs of uninfected animals
expressed TIM-3, after HSV infection TIM-3
+ cells were
numerous. This increase in TIM-3
+CD8
+ T cells was evident at
day 3 pi in the PLN and day 4 in the spleen (Figure S1) and peak
frequencies (Fig 1A and B), as well as total numbers (Fig 1C), were
present on days 6. The majority of TIM-3
+ T cells isolated from
infected animals were CD44
hi and CD62L
lo suggesting that only
activated or effector T cells expressed surface TIM-3
+ (Fig 1D).
Using tetramers and the ICCS assay to detect SSIEFARL
specific CD8
+ T cells (this represents the immunodominant
response to HSV in C57BL6 mice [13], almost all cells were
TIM-3
+ at the peak response time (Fig 1E and F). Additionally, the
frequency of IFN-c-producing peptide-specific T cells was
comparable for both KLRG1
+ and TIM-3
+ cells, further
indicating that TIM-3 is a marker for effector cells (Fig 1G).
The additional TIM-3
+CD8
+ T cells that were not SSIEFARL
specific would likely be recognizing other HSV antigens, but this
could not be verified for lack of additional reagents. However, it
was also conceivable that some of the TIM-3
+ cells were not HSV
specific and represented a bystander-activated population, which
has been advocated to occur in some HSV-induced immunopath-
ological lesions [14]. To address the involvement of bystander
activation different numbers of P14 transgenic CD8
+ T cells (these
recognize the gp33 peptide of LCMV [15] and are not known to
show any cross-reactivity with HSV), were transferred into B6
animals that were subsequently footpad infected with HSV. After
5 days, the expression of TIM-3 was analyzed on Thy1.1
+gp33-
tetramer
+ and Kb-gB Tet
+ CD8
+ T cells. As is evident from
Fig 2A-C, we failed to detect any P14 T cells that expressed TIM-3
on their surface, but in the same animals almost all of the
responding HSV specific cells detected by the Kb-gB-tetramer
were TIM-3
+. These data add no support for bystander
mechanisms causing TIM-3 expression on CD8
+ T cells. It likely
means that all TIM-3
+CD8
+ T cells were reacting with viral
antigens, but this needs to be formally shown.
Galectin-9 induces apoptosis of CD8
+ T cells in vitro
The results of previous in vitro studies have revealed that Gal-9
binding to TIM-3 receptors on some, although not all, T cell
subsets causes them to undergo apoptosis [8,16]. To test the fate of
the CD8
+TIM3
+ population expanded by HSV infection to Gal-9
exposure, PLN cells were collected 6 days pi and exposed in vitro
for 5 hrs to a range of concentrations of Gal-9. Subsequently, the
cells were analyzed by FACS for changes in the expression levels of
TIM-3 and annexin V, the latter indicative of apoptosis [17]. As
shown in Fig 3A, approximately 15% of CD8
+ T cells were TIM-
3
+ at the onset of culture and this percentage did not change
significantly in the absence of Gal-9. However, Gal-9 addition
(at1.0 mM) caused a loss of almost all cells that were TIM-3
+
(Fig 3A upper panel). Baseline levels of annexin V
+ cells also did
not change significantly in the absence of Gal-9 (or in the presence
of Gal-3, as shown in Fig 3E-F). However, when optimal amounts
of Gal-9 were present, annexin V
+ cells increased 15–20% beyond
baseline numbers (Fig 3A upper panel and 3B). This number
roughly correlated with the fraction of TIM-3
+CD8
+ T cells that
disappeared upon Gal-9 exposure. Under the conditions used, we
failed to detect significant numbers of TIM-3
+ annexin V
+ cells,
although at earlier time points some such cells can be
demonstrated (data not shown). In additional experiments, we
measured the effects of Gal-9 addition on the fate of Tet
+ TIM-3
+
CD8
+ T cells, almost all of which as described previously were
TIM-3
+. As shown in Fig 3C (upper panel) and 3D, the great
majority of Tet
+ TIM-3
+ T cells were lost after Gal-9 exposure and
there was a large increase in annexin V
+ T cells.
In other experiments with Gal-9 treated cultures, we investi-
gated the effects of adding an excess of a-lactose, the sugar that
binds to the carbohydrate binding domain of Gal-9 and reduces
Gal-9 binding to TIM-3 [9,16]. In such experiments, lactose
addition served to prevent the disappearance of most TIM-3
+ as
well as Tet
+CD8
+ T cells and also reduced the increase in annexin
V
+ cells (Fig 3A, lower panel and 3B as well as 3C, lower panel
and 3D). Taken together, our results imply that Gal-9 binding to
TIM-3
+ effectors caused their death by apoptosis. It is also
conceivable that binding of Gal-9 to TIM-3 masks its detection or
causes TIM-3 down regulation, but such effects have not been
noted in other systems.
Galectin-9 is up regulated in the lymphoid tissues
responding to HSV infection
The observation that most of the CD8
+ T cells expanded by
HSV infection express TIM-3, along with in vitro observations
that exposure to Gal-9 caused the deletion of TIM-3
+CD8
+ T
cells, could indicate that endogenously produced Gal-9 acts
likewise and serves to limit the magnitude of the anti-HSV
CD8
+ T cell response. In consequence, we determined if
endogenous levels of Gal-9 could be demonstrated in lymphoid
extracts of HSV infected animals, as well as to measure if these
levels changed at different time points after infection. The
quantification of Gal-9 was done by both western blotting and
ELISA (Fig 3H and I and Figure S2). Basal levels of Gal-9 were
detectable in control lymphoid extracts and levels were moderately
increased 2 days p.i. A greater increase (2–2.5 fold) was also
observed in 7 days pi samples (Fig 3H). Accordingly, a
consequence of HSV infection is an increase in endogenous Gal-
9 levels, particularly around the peak time of CD8
+ T cell
responses.
Animals unable to produce Gal-9 mount better acute
phase virus-specific CD8
+ T cell responses
If indeed endogenous Gal-9 production acts to constrain the
magnitude of the CD8
+ T cell responses, then conceivably mice
unable to produce Gal-9 due to gene knockout (KO) would
respond with higher responses to HSV than WT animals. To
evaluate this concept, age and gender matched WT and Gal-9 KO
animals were infected via the footpads with HSV and the
magnitude of CD8
+ T cell responses were compared 5–6 days
later (Fig 4). As shown at day 5.5 days pi, the frequencies (Fig 4A,
B and E for Tet
+ cells and Fig 4D and E for cytokine producing
cells) and absolute numbers (Fig 4F) of virus-specific CD8
+ T cells
in the PLN as measured by tetramers and the ICCS assay, were
increased up to 3 fold in the Gal-9 KO compared to WT mice.
The expression levels of CD44 were higher and CD62L lower on
CD8
+ T cells from Gal-9 KO animals compared to WT (Fig 4C).
This indicates that the more cells from KO animals were in
activated state than those from WT animals. In experiments to
compare the responses to HSV infection of Gal-9 and WT mice at
Gal-9/TIM-3 Pathway in Anti-Viral Immunity
PLoS Pathogens | www.plospathogens.org 4 May 2010 | Volume 6 | Issue 5 | e1000882Figure 1. TIM-3 expression is up regulated on virus-specific CD8
+ T cells after HSV infection. C57BL/6 animals were infected in each hind
footpad with 2.5610
5 PFU of HSV. At different time points after infection, draining popliteal LNs (PLNs) cells isolated from three animals at each time point
were analyzed flow cytometrically for TIM-3, Kb-gB-tetramer and IFN-c staining. A. FACS plots showing the frequencies of TIM-3
+ (upper panel), Kb-gB-Tet
+
(middlepanel)andSSIEFRAL-peptidestimulatedIFN-cproducing(lowerpanel)CD8
+Tcellsareshown.Percentages(B)andabsolutenumbers(C)ofTIM-3
+,
Kb-gB-Tet
+a n dSS IE FR A L -p e p ti d es ti m ul a t e dIF N - cproducing CD8
+TcellsinthedrainingPLNofHSVinfectedanimalsareshown.D.Co-expressionofTIM-3
(upper panel) and Kb-gB-Tet (lower panel) withCD44 and CD62L is shown by representative FACS plots. E.FACS plotsshowing IFN-c productionby TIM-3
+
(upper panel) and Kb-gB-Tet
+expression byTIM-3
+CD8
+Tcellsareshown.F.RepresentativeFACSplotsshowTIM-3expressiononKb-gB-Tet
+(upper panel)
and IFN-c
+CD8
+ T (lower panel) cells G. FACS plots show the expression of TIM-3 (upper panel) and KLRG1 (lower panel) on IFN-c producing CD8
+ T cells.
doi:10.1371/journal.ppat.1000882.g001
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was observed at all times tested although there was a trend of
greater differences after day 10dpi (Figure S3).
To provide evidence for a change in the quality of the CD8
+ T
cell response caused by the absence of Gal-9, we measured and
compared mean fluorescence intensities (MFI) values for some
cytokines as well as the proportions of responder T cells that
produced two compared to a single cytokine. These properties
have been advocated to indicate the presence of high quality T
cells [18]. Our results demonstrate that in Gal-9 KO mice there
was significantly increased frequencies (Fig 4D and E) and
numbers (Fig 4F and G) of IFN-c
+TNF-a
+ T cells, as well as a
higher frequency of cells that had high MFI levels (Fig 4H)
compared to WT mice. Additionally, IFN-c
+IL-2
+ T cell numbers
were also increased in Gal-9 KO as compared to WT animals
(Figure S4).
To measure the functional significance of the differential CD8
+
T cell responses to HSV in Gal-9 KO and WT mice, in vivo
cytotoxicity assays were performed after the peak time responses
on 11 dpi. In these experiments animals received mixed transfers
of 10
7 CFSE labeled splenocytes that were pulsed with the MHC
class I restricted SSIEFARL-peptide of HSV 1 (CFSE
hi) along
with 10
7 un-pulsed cells (CFSE
lo). To ensure the equal distribution
in vivo of peptide pulsed and un-pulsed cells, the same numbers of
both cell types were transferred into uninfected animals. After
2 hrs of transfer, spleens and blood samples were collected and
analyzed by flow cytometry to measure differential killing of
targets in WT and Gal-9 KO animals. Minimal killing of peptide
pulsed splenocytes was seen in uninfected WT or the Gal-9 KO
animals (data not shown). As is evident in Fig 4M and N, in the
absence of Gal-9, CD8
+ T cells were 3 to 4 times more effective at
killing targets as compared to what occurred in WT animals.
Accordingly, this indicates that endogenously produced Gal-9 may
act to limit the effectiveness of virus-specific CD8
+ T cell responses
in vivo.
In other experiments, the ability of Gal-9 KO and WT animals
were compared for their efficiency at clearing infectious virus from
the infected footpad. As shown in Fig 4I, levels of virus in footpad
homogenates measured at day 5.5 pi were 1.5 log lower on
average in Gal-9 KO compared to samples from WT. Differences
were also evident at other time points (data not shown). The results
of both in vivo cytotoxicity and viral clearance experiments
indicate that Gal-9 KO animals have more effective immunity to
HSV.
Galectin-9 Knockout animals mount stronger memory
CD8
+ T cell responses
Comparisons of the magnitude and quality of HSV specific
CD8
+ T cell responses of Gal-9 KO and WT animals were also
made 32 and 60 days pi to record memory phase effects. The
results of a sample experiment, done at 60 days pi, are recorded in
Fig 5. As in the acute phase, the memory responses of Gal-9
animals exceeded those of WT animals. Thus, the frequencies
(Fig 5A) and total numbers (Fig 5C) of CD8
+ and Kb-gB Tet
+ T
cells were increased by approximately 2.5 fold in Gal-9 KO, as
compared to those of WT animals. In addition, the frequency and
numbers of peptide-specific CD8
+ T cells that produced both IFN-
c and TNF-a cytokines was also significantly higher in the spleens
Figure 2. TIM-3 is expressed on TCR stimulated CD8
+ T cells. C57BL/6 animals were injected i.v. with varying numbers of splenocytes isolated
from P14 transgenic animals (Thy1.1) before infection with HSV. 5 days pi PLN and spleens were isolated and analyzed for the expression of TIM-3 on
Kb-gB-Tet
+ and Db-gp33-41-Tet
+ CD8
+ T cells. A-B. FACS plots showing the expression of TIM-3 on Kb-gb-Tet
+ (A) and Db-gp33-41-Tet
+ (B) isolated
from PLN. C. Expression of TIM-3 on endogenous and donor Db-gp33-41-Tet
+CD8
+ T cells when varying numbers of P 14 cells were transferred.
doi:10.1371/journal.ppat.1000882.g002
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PLoS Pathogens | www.plospathogens.org 6 May 2010 | Volume 6 | Issue 5 | e1000882Figure 3. Galectin-9 induces apoptosis of TIM-3 expressing CD8
+ T cells in vitro and its expression is up regulated in the lymphoid
organs after HSV infection. PLNs single cell suspension isolated 6 dpi from HSV infected animals were incubated for 5 hr with varying
concentrations of galectin-9 in the absence or the presence of a-lactose. The experiments were repeated multiple times with similar results. A.
Representative FACS plots showing the expression of TIM-3 and annexin-V on gated CD8
+ T cells under indicated incubation conditions are shown. B.
The bar diagram shows the numbers of TIM-3
+CD8
+ T cells as calculated from A. C. Representative FACS plots showing the expression of Kb-gB-Tet
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higher quality memory responses. Accordingly, in the absence of
Gal-9, memory CD8
+ T cell responses to HSV were increased.
Some WT and Gal-9 KO animals primed 32 days previously
were re-infected in the footpad with HSV and the response in the
PLN measured 2.5 days later by tetramers, ICCS and ex-vivo
proliferative assays. Once again, the frequencies (Fig 5E and G)
and numbers (Fig 5H) of Kb-gB-Tet
+ and cytokine producing cells
(Fig 5F-H) as well as peptide-specific proliferative responses (Fig 5J)
were greater in Gal-9 KO as compared to WT animals. Although,
the ratio of double vs single cytokine producers were not
significantly different, the cells obtained from Gal-9 KO animals
did show higher MFI for IFN-c than those of WT animals (Fig 5I).
Taken together the results of comparisons of the immune
responses to HSV in Gal-9 KO and WT animals at the memory
stage also revealed that Gal-9 might act in normal animals to limit
the magnitude and efficiency of CD8
+ T cell responses.
How does Gal-9 influence CD8 responses in vivo?
Our observation that Gal-9 KO mice develop superior CD8
+ T
cell responses to HSV infection could be explained by the Gal-9
KO CD8
+ T cells being intrinsically more responsive or being less
inhibited when Gal-9 is absent in the environment. To further
evaluate the situation, two types of experiments were done. In one
approach, Thy1.2 naı ¨ve Gal-9 KO or WT CFSE labeled LN cells
were transferred into Thy1.1 animals that were then infected via
the footpad with HSV. In such experiments, no significant
differences in the extent of proliferation by Gal-9 KO and WT
CD8
+ T cells could be observed (Fig 6A-C). This indicates that
intrinsic reactivity differences between Gal-9 KO and WT T cells
did not account for enhanced responses of Gal-9 KO animals.
In another approach, CFSE labeled naive splenocytes from
Thy1.1 animals were transferred either into WT or Gal-9 KO
animals that were subsequently infected via the footpad with HSV.
Cell proliferation was measured by CFSE dilution in the donor
cells and the total numbers of Kb-gB Tet
+ donor cells that had
accumulated in the PLN after 5 days were quantified. The donor
cells proliferated to a similar degree in both recipient types
(Fig 6D), but the accumulation of Kb-gB Tet
+ specific cells 5 day
later was approximately 4 fold higher in the Gal-9 KO than in
WT animals (Fig 6E). In an additional in vitro experiment to
compare the proliferative potential of Gal-9 KO and WT CD8
+ T
cells, CFSE labeled purified CD8
+ T cells were stimulated with
plate-bound anti-CD3 and anti-CD28 mAb for three days and the
extent of CFSE dilution was measured. As shown in Fig 6F, both
CD8
+ T cell populations proliferated equally well. These ex-vivo
and in-vivo results were consistent with the extrinsic environment
accounting for the observed differences in the responsiveness of
CD8
+ T cells in Gal-9 KO and WT animals.
Why does the environment of Gal-9 KO animals enhance
HSV-specific CD8
+ T cell responses?
A likely explanation for the better CD8
+ T cell response to HSV
of Gal-9 KO mice compared to WT mice is that the specific TIM-
3
+CD8
+ T cell effectors will not undergo apoptosis in the absence
of Gal-9. However, a contribution by the Foxp3+ regulatory T cell
(Tregs) response could also be part of the explanation. In support
of this we showed that compared to WT mice, Gal-9 KO animals
had fewer Tregs (Fig 6G and H), especially those that were
CD103
+ (Fig 6K) and TIM-3
+ (Fig 6L). Furthermore, the
expression levels of Foxp3 (Fig 6G, I and J) and activation
markers, such as CD103, TIM-3 and CD44, were lower on Tregs
isolated from Gal-9 KO mice compared to those from WT
animals (Fig 6K-M). Since, the CD8
+ T cell response to HSV can
be inhibited by Tregs [19,20], having fewer of these cells,
especially in the activated state, may also help explain why Gal-
9 KO animals responded better than WT to HSV. That, Gal-9
KO mice have less natural Foxp3
+ Tregs than WT animals after
immunization with non-viral antigens has been reported by others
[21].
Reversal of Gal-9 inhibition of CD8
+ T cell responses in
vivo using a-lactose
Further evidence that endogenously produced Gal-9 may be
acting in vivo to limit the extent of antiviral CD8
+ T cell responses
was obtained by infusing an excess of the sugar that binds to Gal-9
and which interferes with its binding to the TIM-3 receptor. To
this end, HSV infected animals were infused ip twice daily with
200 mlo fa-lactose solutions (27 mM, 137 mM, 277 mM,
416 mM) starting from day 3 until day 5. Subsequently, virus-
specific CD8
+ T cell responses were quantified 12 hr later and
compared to untreated controls. As shown in Fig 7A-F, mice
infused with 277 mM a-lactose had significantly enhanced and
higher quality CD8
+ T cells responses than untreated controls.
The effect was dose dependant with the 277 mM lactose solution
giving the maximal effect (Fig 7A). With this dose, the numbers of
gB498–505 peptide stimulated IFN-c producing CD8
+ T cells at
peak response times were increased 2–3 fold in the PLN and .3
fold in the spleen compared to control animals (Fig 7B, D and E).
A similar pattern of results was revealed using Kb-gB Tet
+, TIM-3
and KLRG-1 to measure results (Fig 7C). Interestingly, the a-
lactose recipients also had a small but significantly higher ratio of
double:single cytokine producing cells indicative of better quality
responses (Fig 7F). We also quantified the viral loads in the
footpads of HSV infected animals that were either treated with a-
lactose or PBS alone. Viral loads were less (p#0.05) in a-lactose
treated animals at day 6 pi than in controls (Fig 7G).
Virus-specific CD8
+ T cell responses were also compared at 32
days pi in a-lactose treated and control animals in limited studies.
A small, but significant increase in the frequencies (Fig 7H) as well
as numbers (Fig 7I) of Kb-gB Tet
+T cells, IFN-c
+ and TNFa
+
-producing CD8
+ T cells (Fig 7J-L) was observed in the a-lactose
treated animals. No significant changes in the number of double
cytokine-producing cells between groups were detected.
We also measured the phenotype and function of the Foxp3
+
Treg isolated from control and a-lactose treated animals at day 5.5
pi (Fig 8A-F). The mean fluorescence intensities of Foxp3, CD103
and TIM-3 expression were decreased in Treg isolated from a-
and annexin-V on gated CD8
+ T cells under indicated incubation conditions are shown. D. The bar diagram shows the numbers of TKb-gB-Tet
+CD8+ T
cells as calculated from C. E. TIM-3 and annexin-V expression on gated CD8
+ T cells isolated from PLNs of HSV infected mice at 6 dpi and incubated for
5 hr with different concentrations of galectin-3 is shown. F. The bar diagram shows the numbers of TIM-3
+CD8
+ T cells as calculated from E. G.
Immunoblots showing galectin-9 expression in the homogenates of isolated PLNs (upper panel) and spleens (middle panel) obtained from HSV
infected animals at different time points are shown. Expression of b-actin as sample loading control is shown in the bottom panel. (lane # 1, day 0;
#2, day 2, #3, day 3.5, #4, day 5, #5, day 8 and #6, recombinant galectin-9). H. Galectin-9 concentrations as measured by sandwich ELISA using
anti-Gal-9 mAb (1A2) in the PLN homogenates is shown. The experiments were performed three times and three animals were sacrificed at each time
point.
doi:10.1371/journal.ppat.1000882.g003
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PLoS Pathogens | www.plospathogens.org 8 May 2010 | Volume 6 | Issue 5 | e1000882Figure 4. Galectin-9 knockout animals mount stronger virus-specific CD8
+ T cell responses in the acute phase. Virus-specific CD8
+ T
cell responses were compared among age and gender matched HSV infected wild type (WT) and galectin-9 knockout (Gal-9 KO) animals at 5.5 dpi.
The experiments were repeated three times with similar results. A. Representative FACS plots showing TIM-3 expression on CD8
+ T cells isolated from
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and F). Additionally, the frequencies and the total number per
PLN of CD103
+ (Fig 8A and B) and TIM-3
+ (Fig 8D and E)
Foxp3
+CD4
+ T cells was also reduced in a-lactose treated animals
as compared to controls. Furthermore, the in vitro suppressive
activity of Foxp3
+CD4
+ T cells isolated from a-lactose treated
animals was also reduced compared to controls when compared by
in vitro suppression assays. These data indicate that inhibition of
Gal-9 binding resulting in a decline of Treg function (Fig 8G).
Taken together, our results with a-lactose infusion to block Gal-
9 activity support the concept that endogenously produced Gal-9
acts to reduce the magnitude and function of anti-HSV CD8
+ T
cell responses. The effect was in part mediated by effects on Treg
responses.
Gal-9 administration diminishes the HSV-specific CD8
+ T
cell response and delays viral clearance
The previous studies all relate to the influence of endogenous
Gal-9 binding to the TIM-3 receptor on virus reactive CD8
+ T
cells. In this experiment, we measured the outcome of adding
exogenous Gal-9 on the magnitude of the anti-HSV CD8
+ T cell
response in HSV infected WT mice. Animals were given 125 mgi p
of Gal-9 during the expansion phase (from day 3 to day 5 pi) and
virus-specific CD8
+ T cell responses were compared with
untreated animals 12 hrs after the last injection. As shown in
Fig 9A-D, the recipients of Gal-9 had significantly reduced
frequencies as well as 2.5 fold reductions in total numbers per PLN
of Kb-gB Tet
+ as well as TIM-3
+ CD8
+ T cells. Furthermore, Gal-
9 treated animals had significantly higher viral loads (1–1.5 logs) in
their footpads compared to controls (Fig 9E).
These experiments demonstrate that exogenous Gal-9 admin-
istration reduces the efficiency of CD8
+ T cell mediated immunity
to HSV infection.
Discussion
This communication investigates the influence of galectin-9
binding to its receptor TIM-3 on the size and quality of CD8
+ T
cell mediated immunity to a virus infection. We demonstrate that
Gal-9 acts to constrain CD8
+ T cell immunity to HSV infection.
In support of this, we show that animals unable to produce Gal-9,
because of gene knockout, develop acute and memory responses to
HSV that are of greater magnitude and better quality than those
that occur in normal infected animals. Interestingly, infusion of
normal infected mice with a-lactose, the sugar that binds to the
carbohydrate-binding domain of Gal-9 limiting its TIM-3 receptor
engagement [9], also caused a more elevated and higher quality
CD8
+ T cell response to HSV. Such sugar treated infected mice
also had expanded populations of memory CD8
+ T cells. The
mechanisms responsible for the outcome of the Gal-9/TIM-3
interaction in normal infected mice involved both inhibitory effects
on TIM-3
+ effector cells, as well as the promotion of Foxp3
+
regulatory T cell activity. Our results indicate that manipulating
galectin signals, as can be achieved using appropriate sugars, may
represent a convenient and inexpensive approach to enhance
acute and memory responses to infectious agents.
Our observation that negating signals delivered by Gal-9
resulted in elevated CD8
+ T cell responses to HSV came as a
surprise. Thus, the expansion of virus specific CD8
+ T cells in Gal-
9 KO mice in the acute response was as much as four fold greater
than occurred in WT animals. We could show that effect was
extrinsically mediated by the presence of Gal-9 during the
development of the immune response. Accordingly, Gal-9 KO
and WT CD8
+ T cells responded equally when transferred into
the virus infected neutral environment. In contrast, WT cells
transferred to a Gal-9 deficient environment responded better to
HSV than occurred when the same cell population was transferred
to mice that could produce Gal-9 normally. Thus, our experiments
support the idea that Gal-9, presumably by its binding to the TIM-
3 receptor, serves to minimize the expansion of the CD8
+ T
effector response to HSV.
Further support for a constraining influence of Gal-9 came from
novel observations in WT mice showing that administering the
sugar a-lactose systemically for three days after HSV infection to
normal mice also resulted in enhanced HSV specific CD8
+ T cell
responses compared to controls. In fact, the response pattern was
similar to that observed in Gal-9 KO animals. Since a-lactose
binds to the carbohydrate-binding domain of Gal-9 [9], it
presumably acted by blunting the interaction of the endogenous
Gal-9 to its TIM-3 receptors. In our studies, a-lactose was
administered on multiple occasions intraperitoneally, but it will be
of interest to determine if the lactose enhancement effect can also
be achieved by an administration procedure that be would be
practical for use with vaccines. This issue is currently being
investigated in our laboratory.
In both Gal-9 KO and sugar inhibited virus infected WT mice,
the consequence of blunting Gal-9 signals was not only an increase
in the magnitude of the HSV-specific CD8
+ T cell response, but
also a change in its quality. The latter conclusion came from the
observation that the frequency of gB peptide specific T cells that
produced multiple cytokines, as well as high cytokine producing
cells, was significantly higher in Gal-9 blunted animals compared
to controls (particularly in the acute phase of the response).
Multiple cytokine production, as well as the presence of high
cytokine producing effector T cells, is commonly used as an
indicator of more functional T cells [18], although formally
showing the functional value of this increased quality in vivo is
rarely done. In our studies, we did show that mice with blunted
the lymphoid organs of WT and Gal-9 KO animals. B. FACS plots showing the co-expression of TIM-3 and Kb-gB-Tet in WT and Gal-9 KO animals. C.
Histograms show the expression of CD62L and CD44 on CD8
+ T cells isolated from the PLNs of infected WT (thin lines) and Gal-9 KO (thick lines)
animals. D. Representative FACS plots show the frequencies of SSIEFARL peptide-stimulated IFN-c and TNF-a producing CD8
+ T cells isolated from the
PLNs of WT and Gal-9KO animals. E & F. The measurement of frequencies (E) and absolute numbers (F) of TIM-3
+, Kb-gB-Tet
+, IFN-c and TNF-a
producing CD8
+ T cells isolated from the PLNs of infected WT (n=6) and Gal-9 KO (n=7) animals as described in A-D are shown. G. The bar diagram
shows the ratios of SSIEFARL stimulated IFN-c
+TNF-a
+ to IFN- c
+ CD8
+ T cells isolated from PLNs of infected WT and Gal-9KO mice as depicted by
FACS plots in D. H. The MFI of cytokines produced by CD8
+ T cells is shown. I. Viral titers obtained from footpad tissues at 5.5 days pi of WT and Gal-9
KO are shown. J-N. Spleens of HSV infected WT and Gal-9 KO animals were analyzed for the measurement of tetramer
+ CD8
+ T cells (J-L) and their
ability to kill peptide pulsed splenocytes (M and N) 11 dpi. Syngenic splenocytes were pulsed with SSIEFARL-peptide and labeled with high
concentration (2.5 mM) of CFSE. As a control of antigen specificity, un-pulsed cells were labeled with low concentration (0.25 mM) of CFSE. 10
7 cells of
each type (CFSE
hi and CFSE
lo) in 1:1 ratio were transferred into in HSV infected WT and Gal-9 KO animals at 11 dpi. 2 hr post infusion, PBMCs and
spleen cells were prepared from each animal and samples were acquired on FACS caliber and analysed by Flowjo software. The percentage of specific
cell killing was determined as described in Materials and Methods section. The frequencies (J and K) and numbers (L) of Kb-gB-tet
+ CD8
+ T cells in the
spleens of WT and Gal-9 KO animals at day 11 pi are shown. M. Representative FACS plots for the percentages of CFSE
hi and CFSE
lo cells are shown. N.
The bar diagrams show the percent specific lysis in the spleens of recipients.
doi:10.1371/journal.ppat.1000882.g004
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establish if the better control was explained by quantitative or
qualitative changes of CD8
+ T cell activity, or perhaps was caused
by effects on other aspects of immune defense. Whatever the
explanation, the observation that blunting reactivity to Gal-9
results in improved immunity requires comment since it seems
counterintuitive in terms of protecting the host against a virus
infection. We advocate that the phenomenon may relate to the
needs of the host to minimize collateral tissue damage that is a
common occurrence especially during chronic T cell responses to
foreign antigens [22,23]. In support of this, reports show that the
Gal-9 signals to TIM-3 help to minimize the severity of
autoimmune lesions [7,24]. For example, Gal-9 KO mice develop
more severe lesions of collagen-induced arthritis than normal
animals [21]. We have also observed that Gal-9 KO mice are
more susceptible than WT animals to the immunopathological
disease herpetic stromal keratitis (SK) (unpublished results). Using
this model, which is a HSV induced lesion in the eye orchestrated
by CD4
+ T cells [25], we have shown that Gal-9/TIM-3
engagement plays a beneficial role. Accordingly, administering
exogenous Gal-9 locally in infected mice minimizes the severity of
SK lesions and can even cause their resolution [8]. Thus, our
Figure 5. Galectin-9 KO animals develop sustained virus-specific CD8
+ T cells memory responses. The lymphoid organs of HSV infected
WT and Gal-9 KO animals were analyzed at day 32 or day 60 after infection for early and long-term memory responses using Kb-gB-tetramer and ICCS
assays. All but long term memory experiments were repeated at least three times with four animals per group. A. Representative FACS plots showing
the frequencies of Kb-gB-Tet
+ cells in the spleens of WT and Gal-9 KO animals at 60 dpi. B. Representative FACS plots showing the frequencies of
SSIEFARL peptide stimulated IFN-c and TNF-a producing CD8
+ T cells at 60 dpi. C. Bar diagram show the absolute numbers of Kb-gB-Tet
+ and IFN-c
producing CD8
+ T cells in the spleens of WT and Gal-9 KO animals as depicted by FACS plots in A and B at day 60. D. The bar diagram shows the ratio
of SSIEFARL stimulated IFN-c
+TNF-a
+ to IFN-c
+ CD8
+ T cells isolated from WT and Gal-9 KO mice at 60 dpi. E-J. The animals previously infected with
HSV for 32 days were re-infected with the same dose of HSV in footpads and the virus-specific CD8
+ T cells responses were quantified in the PLN 2.5
dpi. E. Representative FACS plots show the frequencies of Kb-gB-Tet
+ CD8
+ T cells in the PLNs of WT (n=4) and Gal-9 KO (n=4) animals. F.
Representative FACS plots show the frequencies of SSIFERAL-stimulated IFN-c and TNF-a producing CD8
+ T cell in the PLNs of WT (n=4) and Gal-9
KO (n=4) animals. G-H. The bar diagram shows the frequencies (G) and numbers (H) of Kb-gB-Tet
+ and cytokines producing CD8
+ T cells as depicted
by FACS plots in E and F. I. MFI of cytokines produced by stimulated CD8
+ T cell is shown. J. The peptide-specific proliferative response of PLNs cells
isolated from re-infected animals at 2.5dpi is shown.
doi:10.1371/journal.ppat.1000882.g005
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+ T cell responses. Splenocytes (having 1610
6 of CD8
+
T cells) isolated from either WT or Gal-9 KO animals after labeling with CFSE were transferred in WT Thy1.1 animals (n=4 for each recipient) (A-
C). Alternatively, CFSE labeled splenocytes (having 1610
6 of CD8
+ T cells) isolated from Thy1.1 animals were transferred either in WT or in Gal-9
KO animals (D-E). The recipients were infected with 2.5610
5 HSV in footpad after 24 hr pi. Five dpi spleens and PLN cell suspensions were
analyzed for the dilution of CFSE in transferred Thy1.2
+ or Thy1.1
+CD8
+ T cells. A. FACS plots show the frequencies of transferred Thy1.2
+ WT or
the Gal-9 KO cells in the PLNs of Thy1.1 animals 5 dpi B. The representativeh i s t o g r a m ss h o w i n gt h ee x t e n to fC FSE dilution in the transferred WT
or the Gal-9 KO cells (gated on Thy1.2
+CD8+ T cells as shown in A). C. Absolute numbers of the transferred Thy1.2
+ CD8
+ Tc e l l sW To rt h eG a l - 9
KO cells in the PLNs of recipients. D. The extent of CFSE dilution in the transferred Thy1.1
+CD8
+ T cells isolated 5dpi from WT and Gal-9 KO
animals. E. FACS plots show the co-expression of Kb-gB-Tet and CFSE in the dividing transferred Thy1.1
+CD8
+ T cells isolated from WT and Gal-9
KO animals. F. Purified CD8
+ Tc e l l s( 9 0 %p u r i t y )f r o mW Ta n dG a l - 9K Oa n i m a l sa f t e rC F S E labeling were stimulated with plate bound anti-CD3
and CD28 mAb for 3 days and the extent of proliferation was measured by CFSE dilution in CD8
+ T cells. Red lines show the CFSE staining in Gal-
9 KO, Black thick lines show the CFSE staining in WT cells and black thin lines represent CFSE staining in un-stimulated cells. G-L. The lymphoid
organs of infected WT and Gal-9 KO animals at 6 dpi were isolated and Foxp3
+CD4
+ T cells were characterized. G. FACS plots show the
frequencies of Foxp3
+ Tregs in PLNs (upper panel) and spleens (lower panel) of WT and Gal-9 KO. The percentages (H), MFI of Foxp3 expression
on Foxp3
+CD4
+ Tregs isolated from PLN (I) and spleens (J) of WT and Gal-9 KO animals are shown. K-L. The frequencies of CD103
+ (K) and TIM-3
+
(L) Foxp3
+ Tregs isolated from the draining PLNs (upper panel) and Spleens (lower panel) of WT and Gal-9 KO animals are shown. M. The
expression of CD44 on Foxp3
+CD4
+ T cells isolated from the PLNs (upper panel) and spleens (lower panel) of WT (thin lines) and Gal-9 KO
(thicker lines) animals.
doi:10.1371/journal.ppat.1000882.g006
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+
T cells responses. C57B/6 animals were infected in each footpad with 2.5610
5 pfu of HSV and divided into groups. Animals were treated with
different doses (27 mM, 137 mM, 277 mM, 416 mM) of a-lactose from day 3 until day 5 and those in the other group were given PBS. 12 hrs after last
administration, animals were sacrificed and virus specific CD8
+ T cell responses were quantified. A. Effect of different doses of a-lactose on the
magnitude of virus-specific CD8
+ T cells is shown. B. Representative FACS plots showing the frequencies of IFN-c and TNF-a producing CD8
+ T cells
isolated from the PLN (upper panel) and spleen (lower panel) of a-lactose (277 mM) treated (n=4) and control (n=6) animals are shown. C.
Expression of TIM-3 and CD62L (upper panel), TIM-3 and KLRG1 (middle panel) and Kb-gB-Tet on CD8
+ T cells isolated from control and a-lactose
treated animals are shown. D-E. Frequencies (D) and absolute numbers (E) of IFN-c producing CD8
+ T cells as depicted by FACS plots in B are shown.
F. The bar diagram shows the ratio of SSIEFARL stimulated IFN-c
+TNF-a
+ to IFN-c
+ CD8
+ T cell. G. Viral titers in the footpad tissues of a-lactose treated
and control animals are shown. H-J. HSV infected animals were given 277 mM a-lactose ip day 1 until day 7 and their CD8
+ T cell responses were
compared with that of control animals at 30 dpi. The frequencies (H) and numbers (I) of Kb-gB-Tet
+CD8
+ T cells are shown. J-L. The frequencies (J and
K) and absolute numbers (L) of SSIEFARL stimulated IFN-c and TNF-a producing CD8
+ T cells isolated form control (n=4) and a-lactose treated (n=4)
animals are shown.
doi:10.1371/journal.ppat.1000882.g007
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with its TIM-3 receptor can be detrimental to the efficiency of
protective CD8
+ T cell mediated immunity represents a modest
dispensation by the body to avoid exuberant damaging reactions.
With regard to the mechanisms by which Gal-9 acts to counter
the extent of the CD8
+ T cell response, several events could be
occurring. Most likely, however, the principal mechanism involves
the induction of apoptosis in TIM-3 positive effector cells as we
could demonstrate in vitro. Others too have reported that Gal-9
can cause the apoptosis of some, although not all, subsets of TIM-3
expressing T cells [8,26]. Curiously, as we reported recently, TIM-
3
+Foxp3
+ Tregs do not undergo Gal-9 induced apoptosis for
reasons that are yet to be ascertained. Furthermore, Gal-9
administration into antigen stimulated mice may induce expansion
of the Foxp3
+ T cell population likely by causing some
conventional T cells to become Foxp3
+ and regulatory in function
[8,21]. In fact, one effect of blunting Gal-9 observed in the present
investigations was an expansion of Treg numbers and function.
Thus, lower expression levels of several activation and functional
markers was evident on Foxp3
+ Treg isolated from Gal-9 KO
compared to WT infected animals. Similarly, blunting Gal-9
function with a-lactose produced a similar change in Treg
numbers and phenotype as observed in Gal-9 KO mice.
Furthermore, Foxp3
+ cells isolated from HSV infected Foxp3-
GFP-knock-in mice had lower in vitro suppressive activity when
taken from a-lactose treated than untreated animals.
Since, as we and others have shown previously [19], Treg limit
the magnitude of T cell responses to virus infections, part of the
Figure 8. Administration of a-lactose diminishes regulatory T cells responses. LN cells and splenocytes isolated from HSV infected animals
that were either treated with a-lactose or controls as described in Fig 4, were analyzed for the expression of activation markers and activity. A-C. FACS
plots depicting the expression (% positive (A and B) and MFI (C) of TIM-3 on gated CD4
+Foxp3
+ T cells in the control and a-lactose treated animals are
shown. D-F. FACS plots showing the expression (% positive (D and E) and MFI (F) of CD103 on gated CD4
+Foxp3
+ T cells in the control and a-lactose
treated animals are shown. G. The suppressive activity of Tregs is reduced after a-lactose treatment. Foxp3-GFP Knock-in animals were infected with
HSV and divided into two groups. One group was treated with a-lactose (277mM solution) and the other group of animals was left untreated. GFP
+
cells were sorted after 6 days of HSV infection and co-cultured with CFSE labeled Thy1.1 CD4
+CD25- cells and T cell depleted splenocytes isolated
from uninfected animals Thy1.1 B/6 animals. FACS plots (G) show the extent of dilution of CFSE as an indicator of proliferation in Thy1.1
+CD4
+and its
inhibition in the presence of Tregs. CFSE staining in un-stimulated cells (faint line), stimulated cells in the presence of Tregs isolated from control
animals (thinner line) and stimulated cells in the presence of Tregs isolated from a-lactose treated animals (thickest line) are shown.
doi:10.1371/journal.ppat.1000882.g008
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diminished Treg activity. It is also conceivable that the Treg
involved in limiting the magnitude of CD8
+ T cell responses could
have a distinct phenotype. Thus it was shown recently that Treg
might acquire a genetic program similar to that of the cell type
being suppressed and that unique sets of Treg may be responsible
for controlling different components of immunity [27,28,29]. Our
observations that TIM-3 is up-regulated on Tregs after HSV
infection and that the increased CD8
+ T cell responses were
associated with diminished numbers of TIM-3
+ regulatory T cells
in animals with blunted Gal-9 activity, could also mean that Tregs
that are TIM-3
+ are preferentially involved in controlling CD8
+ T
cell responses. Additional studies are underway to establish the
relative effects of Gal-9 on effectors and regulators, as well as to
further identify the phenotype of the Tregs involved in
constraining HSV specific CD8
+ T cell activity.
Apart from direct effects of Gal-9 on TIM-3
+ T cells, Gal-9 may
also influence some functions of the innate immune system.
Reported effects include enhanced chemotaxis and activation of
granulocytes as well as the maturation of dendritic cells. The latter
effect of Gal-9 was shown to be responsible for an improved anti-
tumor CD8
+ T cell response [30]. We doubt if effects on DCs
explained our findings since populations isolated 24 hrs from the
PLNs after footpad infection of Gal-9 KO mice showed no
significant differences in phenotypic and functional markers than
cells from WT animals (data not shown). However, further
investigation on the influence of galectins on components of innate
immune is currently underway in our laboratory.
Perhaps the most important observation we made was that
animals with blunted Gal-9 signals (Gal-9 KO as well as a-lactose
treated) had expanded populations of memory CD8
+ T cells. At
two months after infection, populations were approximately two-
fold higher. Currently, we cannot explain why more CD8
+ T cells
survive to become memory cells in the absence of Gal-9. Further
studies are underway to determine if the Gal-9 influence is
expressed predominantly during the induction, contraction or
maintenance phases of T cell mediated immune responses, as well
as to explore if modulating Gal-9 levels can influence an already
established pattern of responsiveness. However, an exciting
potential application of our findings is that memory CD8
+ T cell
populations can be expanded using simple sugars. This could
represent an easy, non-toxic and inexpensive way to enhance anti-
microbial immunity. Accordingly, an expanded memory popula-
tion may cause the outcome of re-infection or reactivation by a
pathogen to be subclinical rather than disease producing.
Currently, we know little about the influence of sugars on the
efficiency of innate and adaptive immunity. This issue merits more
investigation.
Figure 9. Administration of galectin-9 during the expansion phase after HSV infection diminishes the magnitude of virus-specific
CD8
+ T cell responses. C57B/6 animals (n=10) were infected in each footpad with 2.5610
5 PFU of HSV and divided into two groups. Animals in
one of the groups were treated with 125 mg of Gal-9 from day 3 until day 5 and those in the other group were given PBS. 12 hr after last injection,
animals were sacrificed and single cell suspensions of their PLNs and spleens were analyzed flow cytometrically for virus specific CD8
+ T cell responses
(surface staining and SSIEFARL peptide stimulated intracellular IFN-c and TNF-a producing CD8 T cells). A. Representative FACS plots for surface
staining of CD8
+ T cells isolated from the PLNs for the expression of TIM-3, CD44, CD62L and Kb-gB-Tet
+ in Gal-9 treated and control animals are
shown. B. Representative FACS plots for the frequencies of peptide stimulated IFN-c and TNF-a producing CD8
+ T cells in the PLN (upper panel) and
spleens (lower panel) are shown. C-D. Frequencies (C) as well as absolute numbers (D) of CD8
+ T cells positive for TIM-3, KB-gb-Tet, IFN-c and TNF-a
isolated from PLNs of control and treated mice are shown. E. The viral titers in the footpads of control and treated animals 12 hrs after last injection as
quantified by standard plaque assays are shown. The experiments were performed two times with 5 animals per group each time.
doi:10.1371/journal.ppat.1000882.g009
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Figure S1 C57BL/6 animals were infected in each hind footpad
with 2.5x10
5 PFU of HSV. At different time points after infection,
splenocytes isolated from three animals at each time point were
analyzed flow cytometrically for TIM-3 and IFN-c expression. A.
Representative FACS plots show the frequencies of TIM-3
+ and
IFN-c
+ in CD8
+ T cell gated populations. B. Frequencies of TIM-
3
+ and IFN-c
+ CD8
+ T cells are shown.
Found at: doi:10.1371/journal.ppat.1000882.s001 (0.25 MB TIF)
Figure S2 C57BL/6 animals were infected in each hind footpad
with 2.5x10
5 PFU of HSV and the concentration of Gal-9 in the
PLN samples of infected animals was measured by sandwich
ELISA using anti-Gal-9 (108A2) mAb.
Found at: doi:10.1371/journal.ppat.1000882.s002 (0.18 MB TIF)
Figure S3 Comparison of antigen-specific CD8
+ T cell respons-
es (measured by ICCS assay) in Gal-9 KO and WT mice at
different times after HSV infection. Age and gender matched WT
and Gal-9 KO animals were infected in footpad with 2.5x10
5 PFU
of HSV KOS. At indicated time points, three animals were
sacrificed and the SSIEFERAL specific IFN-c producing cell
numbers were quantified by ICCS assays. Figure shows the mean
of three observations at each time point.
Found at: doi:10.1371/journal.ppat.1000882.s003 (0.10 MB TIF)
Figure S4 C57BL/6 WT and Gal-9 KO animals were infected
in each hind footpad with 2.5x10
5 PFU of HSV and cytokine
producing CD8
+ T cells were quantified using ICCS assays at
5.5dpi. The FACS plots (A) and bar diagram (B) show the
frequencies of SSIEFARL peptide stimulated IL-2 and IFN-c
producing CD8
+ T cells.
Found at: doi:10.1371/journal.ppat.1000882.s004 (0.27 MB TIF)
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